Rankings
▼
Calendar
PHIO Q1 2020 Earnings — Phio Pharmaceuticals Corp. Revenue & Financial Results | Market Cap Arena
PHIO
Phio Pharmaceuticals Corp.
$13M
Q1 2020 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
-100.0% YoY
Gross Profit
-$45,000
Operating Income
-$2M
Net Income
-$2M
EPS (Diluted)
$-93.67
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$2M
Free Cash Flow
-$2M
Stock-Based Comp.
$43,000
Balance Sheet
Total Assets
$14M
Total Liabilities
$2M
Stockholders' Equity
$12M
Cash & Equivalents
$13M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$21,000
-100.0%
Gross Profit
-$45,000
-$1M
+95.8%
Operating Income
-$2M
-$2M
-9.8%
Net Income
-$2M
-$2M
-10.9%
← FY 2020
All Quarters
Q2 2020 →